As the name goes, the prostate cancer is a common type of cancer affecting the gland known as the prostate, found only in the male’s reproductive system, its location being near the rectum, surrounding the urethra and below the bladder; this organ is also responsible for the storage and the making of the seminal fluid.



“Cancer” is a reference term used in defining the abnormal condition of the rapid and uncontrollable growth of the body’s cells; the newly formed cancerous cells usually outlive the normal ones.

The tumor means the abnormal growth of the cells, and, according to how spread is in the body, it is categorized as a primary and secondary tumor, the primary being the original one.

The prostate cancer can be described as the existence of very small and multiple primary tumors in the prostate organ. Under normal conditions, in this stage, the disease doesn’t present any early symptoms, but if it is detected with the screening tests, the cancer could be treated with radiation therapy or prostatectomy.

If the tumor is left untreated, the cancerous cells tend to multiply abnormally and the cancer will eventually spread to the surrounding areas of the prostate as the rectum, bones, lymph nodes in the groin area or the seminal vesicle; this is the stage known as the metastatic cancer, when the cancerous prostate cells are being transported through the bloodstream and the lymphatic system to other internal regions of the body where they grow other tumors. The results of the treatments will vary according to how spread is the cancer in the organism.

Even if cancer is the most common known prostate disease, there are also certain disorders related to the malfunctioning of this organ like benign prostatic hyperplasia (BPH) or prostatitis.

The prostate cancers are classified as adenocarcinomas, developing in the glandular tissue and small cell anaplastic cancer or neuro-endocrine cancer, which spreads earlier but doesn’t produce the prostate specific antigen also known as PSA.

Prostate cancer is the most common non-skin cancer in the United States, affecting almost one in six men; there is a thirty five percent possibility that a man will most likely develop a prostate cancer disease than a woman, a breast cancer.

Believe it or not, when the prostate cancer was officially recognized for the first time by the medical community in 1853, it was considered as a rare disease because of the short life expectancies and lack of medical information about it. In fact, in the last 1500’s, Niccolo Massa, a Venetian anatomist, made the first attempt to describe the prostate gland and the symptoms of the prostate disorders, while illustrations of it, dating from the same period of time, are being attributed to Andreas Vesalius, a Flemish anatomist.

This disease, as I’ve stated several times in this article, is a very common illness, and this should be enough to have you thinking about giving a chance to the medical technology used in preventing and diagnosing all types of cancer, because the results of the future treatment will very much depend on how aggressive and spread is the malignant tumor in the body.

So regularly perform those recommended screening tests.